Report cover image

Next Generation Sequencing Markets (Systems, Consumables, Services, Competitive Analysis, Trends, Platforms)

Published Sep 07, 2016
Length 533 Pages
SKU # KLI15104387

Description

This report, Next Generation Sequencing Markets (Systems, Consumables, Services, Competitive Analysis, Trends, Platforms)  covers the market for NGS including a market estimate and a projection to 2020, regional growth for North America, Europe and Other regions, markets by disease category and instrument popularity from lab self reporting surveys.   The report also covers investments in sequencing, trends and detail about manufacturers and service companies in NGS.   A unique feature of this report is its focus on the interplay between in vitro diagnostics (IVD) and sequencing, with detailed examples of diagnostic companies and clinical laboratories that have made agreements in next generation sequencing.  Illumina, Thermo Fisher and other companies are analyzed in the report.  

    Table of Contents

    533 Pages
      • Overview
      • Scope and Methodology
      • Market Overview
      • Future Prospects in the Sequencing Market
      • Overview - Next Generation Sequencing Market Is Rapidly Changing
      • History of DNA Sequencing
      • Point-of-View
      • Sanger Sequencing
      • Next-Generation Sequencing
      • Sequencing Applications/Types of Sequencing
      • Sample or Library Preparation
      • Information Technology
      • Sample-to-Answer (Sample-to-Insight) Workflows or Platforms
      • Rapid Next Generation Sequencing Testing
      • Research, Drug Discovery and Development
      • Clinical Diagnostic Applications of Sequencing
      • Direct-to-Consumer Genetic Testing Industry
      • Investments and Financing Agreements
      • Mergers and Acquisitions
      • Other Corporate Agreements and Collaborations
      • Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government
      • Overcoming Technology Hurdles - Sample Preparation and Data Analysis
      • Advances in Next Generation Sequencing Platforms
      • Next Generation Sequencing Market Drivers
      • Issues and Hurdles Faced by NGS Companies Selling to the Research Market
      • Issues and Hurdles Faced by Clinical Laboratories Doing NGS
      • Regulation of Next Generation Sequencing-Based In Vitro Diagnostic (IVD) Tests
      • Regulation of Companion Diagnostics
      • Complexities of Companion Diagnostic Tests and Corresponding Therapeutic Products; Harmonization of Companion Diagnostic Tests Across a Class of Targeted Therapies
      • Cost and Reimbursement Issues
      • Competition
      • Future Prospects
      • Sequencing Market Overview
      • Sequencing Market - Geographical Distribution
      • Brand Ownership
      • Sequencing Market - Research versus Clinical Use
      • Sequencing Methods/Applications
      • Clinical Sequencing Market - Disease Indications
      • Analysis of Deals Activity in Next Generation Sequencing
      • 10x Genomics, Inc.
      • 23andMe, Inc.
      • Abbott Laboratories
      • ACT Genomics Co., Ltd.
      • Adaptive Biotechnologies Corporation
      • Admera Health
      • Advanced Biological Laboratories (ABL), S.A
      • Agilent Technologies Inc.
      • AltheaDx, Inc.
      • Ambry Genetics Corp.
      • Aperiomics, Inc.
      • Asuragen, Inc.
      • Athena Diagnostics, Inc. (A Quest Diagnostics Business)
      • Base4 Innovation Ltd
      • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
      • Becton, Dickinson and Company (BD)
      • BGI
      • Bina Technologies, Inc. (Part of Roche Sequencing)
      • BioDiscovery, Inc.
      • Biomatters Ltd.
      • bioMérieux SA
      • bioTheranostics, Inc.
      • Cancer Genetics, Inc.
      • CareDx, Inc.
      • Caris Life Sciences
      • CLC bio (A QIAGEN Company)
      • Color Genomics, Inc.
      • Complete Genomics (A BGI Company)
      • Courtagen Life Sciences, Inc.
      • Cynvenio Biosystems, Inc.
      • DNA Electronics Ltd.
      • Eurofins Genomics
      • Exosome Diagnostics, Inc.
      • Foundation Medicine, Inc.
      • GATC Biotech AG
      • GenapSys, Inc.
      • GenDx
      • GENEWIZ Inc.
      • Genia Technologies, Inc. (Part of Roche Sequencing)
      • Genomic Health, Inc.
      • Genoptix (A Novartis Company)
      • GnuBIO, Inc. (A Bio-Rad Company)
      • GRAIL
      • Guardant Health, Inc.
      • Helix
      • HTG Molecular Diagnostics
      • Human Longevity, Inc.
      • Illumina, Inc.
      • Inivata Ltd.
      • Invitae Corporation
      • Invivoscribe Technologies, Inc.
      • Laboratory Corporation of America (LabCorp)
      • Lasergen, Inc.
      • MolecularMD Corporation
      • Myriad Genetics, Inc.
      • NANTOMICS (Member of the NantWorks ecosystem of companies)
      • Natera, Inc.
      • NeoGenomics, Inc./NeoGenomics Laboratories
      • N-of-One, Inc.
      • OncoDNA SA
      • Oncospire Genomics
      • Oxford Nanopore Technologies Ltd.
      • Pacific Biosciences of California, Inc.
      • Pathway Genomics Corporation
      • Personal Genome Diagnostics, Inc.
      • Personalis, Inc.
      • QIAGEN N.V.
      • Quest Diagnostics
      • RainDance Technologies, Inc.
      • Roche
      • Siemens Healthcare Diagnostics
      • Stratos Genomics Inc.
      • Sysmex Corporation
      • Thermo Fisher Scientific, Inc.
    How Do Licenses Work?
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.